Głowacka-Rutkowska Aleksandra, Gozdek Agnieszka, Empel Joanna, Gawor Jan, Żuchniewicz Karolina, Kozińska Aleksandra, Dębski Janusz, Gromadka Robert, Łobocka Małgorzata
Department of Microbial Biochemistry, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.
Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland.
Front Microbiol. 2019 Jan 18;9:3227. doi: 10.3389/fmicb.2018.03227. eCollection 2018.
Phage vB_SauP_phiAGO1.3 (phiAGO1.3) is a polyvalent lytic podovirus with a 17.6-kb genome (Gozdek et al., 2018). It can infect most of the human isolates of dominant clonal complexes. We show that a major factor contributing to the wide host range of phiAGO1.3 is a lack or sparcity of target sites for certain restriction-modification systems of types I and II in its genome. Phage phiAGO1.3 requires for adsorption β--GlcNAcylated cell wall teichoic acid, which is also essential for the expression of methicillin resistance. Under certain conditions an exposure of to phiAGO1.3 can lead to the establishment of a mixed population in which the bacteria and phages remain in equilibrium over multiple generations. This is reminiscent of the so called phage carrier state enabling the co-existence of phage-resistant and phage-sensitive cells supporting a continuous growth of the bacterial and phage populations. The stable co-existence of bacteria and phage favors the emergence of phage-resistant variants of the bacterium. All phiAGO1.3-resistant cells isolated from the phage-carrier-state cultures contained a mutation inactivating the two-component regulatory system ArlRS, essential for efficient expression of numerous virulence-associated traits. Moreover, the mutants were unaffected in their susceptibility to infection with an unrelated, polyvalent phage of the genus . The ability of phiAGO1.3 to establish phage-carrier-state cultures did not preclude its antistaphylococcal activity in an nematode infection model. Taken together our results suggest that phiAGO1.3 could be suitable for the therapeutic application in humans and animals, alone or in cocktails with phages. It might be especially useful in the treatment of infections with the majority of methicillin-resistant strains.
噬菌体vB_SauP_phiAGO1.3(phiAGO1.3)是一种多价裂解性短尾病毒,基因组大小为17.6 kb(戈兹德克等人,2018年)。它能感染大多数优势克隆复合体的人类分离株。我们发现,phiAGO1.3宿主范围广泛的一个主要因素是其基因组中缺乏或稀少某些I型和II型限制修饰系统的靶位点。噬菌体phiAGO1.3吸附需要β - 糖基化的细胞壁磷壁酸,这对耐甲氧西林表达也至关重要。在某些条件下,暴露于phiAGO1.3可导致建立一个混合群体,其中细菌和噬菌体在多代中保持平衡。这让人联想到所谓的噬菌体携带状态,使噬菌体抗性细胞和噬菌体敏感细胞能够共存,支持细菌和噬菌体群体的持续生长。细菌和噬菌体的稳定共存有利于细菌产生噬菌体抗性变体。从噬菌体携带状态培养物中分离出的所有phiAGO1.3抗性细胞都含有使双组分调节系统ArlRS失活的突变,该系统对许多毒力相关性状的有效表达至关重要。此外,这些突变体对感染无关的多价噬菌体属的敏感性没有受到影响。phiAGO1.3建立噬菌体携带状态培养物的能力并不排除其在秀丽隐杆线虫感染模型中的抗葡萄球菌活性。综上所述,我们的结果表明,phiAGO1.3单独或与噬菌体混合使用可能适用于人类和动物的治疗应用。它在治疗大多数耐甲氧西林菌株感染方面可能特别有用。